文献速递肝胆胰外科围术期管理与 ERAS

术中近红外成像可识别胰腺肿瘤并辅助实时切缘评估

Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection.
PubMed 文献 · Ann Surg · 2019-01-01

该开放标签临床试验纳入20例胰腺切除术患者,术前24小时给予第二窗口吲哚菁绿(ICG),术中行近红外(NIR)成像。13例浸润性恶性肿瘤中12例呈现荧光(平均TBR 4.42±2.91),切缘荧光与最终病理评估在13例中12例一致;第二窗口ICG可靠聚集于浸润性胰腺恶性肿瘤,可在胰腺切除术中提供实时反馈。

要点

  • 第二窗口ICG在浸润性胰腺恶性肿瘤中可靠聚集,可术中实时识别肿瘤。
  • 切缘荧光与最终病理评估在13例中12例一致,有望辅助实时切缘判断。
  • 新辅助治疗后无治疗反应的4例肿瘤均荧光,1例显著反应者无荧光。

核心结论

  • 第二窗口ICG可靠聚集于浸润性胰腺恶性肿瘤,可在胰腺切除术中提供实时反馈。
  • NIR成像可能有助于评估新辅助治疗的反应。

研究设计与样本

  • 开放标签临床试验,2016年7月至2018年5月纳入20例患者。
  • 术前24小时给予第二窗口ICG(2.5-5 mg/kg),术中及离体标本行NIR成像。
  • 共获得21份标本,包括9例胰十二指肠切除术、10例远端胰腺切除术和1例全胰腺切除术。

主要发现

  • 8例非浸润性肿瘤中3例有荧光(平均TBR 2.59±2.57)。
  • 13例浸润性恶性肿瘤(12例胰腺腺癌、1例胆管癌)中12例有荧光(平均TBR 4.42±2.91)。
  • 切缘荧光与最终病理评估在13例中12例一致。
  • 新辅助治疗后5例肿瘤中4例有荧光,这4例病理评估无治疗反应;1例显著治疗反应者无荧光。

临床怎么用

  • 胰腺切除术中可考虑使用第二窗口ICG联合NIR成像辅助识别浸润性肿瘤和评估切缘。
  • NIR成像荧光结果可能辅助判断新辅助治疗反应,但需进一步验证。

局限性

  • 样本量小(20例患者、21份标本),为开放标签单臂试验。
  • 非浸润性肿瘤荧光比例较低,诊断准确性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if intraoperative near-infrared (NIR) imaging carries benefit in resection of pancreatic neoplasms. BACKGROUND: Resection of pancreatic malignancies is hindered by high rates of local and distant recurrence from positive margins and unrecognized metastases. Improved tumor visualization could improve outcomes. We hypothesized that intraoperative NIR imaging with a clinically approved optical contrast agent could serve as a useful adjunct in assessing margins and extent of disease during pancreatic resections. METHODS: Twenty patients were enrolled in an open-label clinical trial from July 2016 to May 2018. Subjects received second window indocyanine green (ICG) (2.5-5 mg/kg) 24 hours prior to pancreatic resection. NIR imaging was performed during staging laparoscopy and after pancreas mobilization in situ and following resection ex vivo. Tumor fluorescence was quantified using tumor-to-background ratio (TBR). Fluorescence at the specimen margin was compared to pathology evaluation. RESULTS: Procedures included 9 pancreaticoduodenectomies, 10 distal pancreatectomies, and 1 total pancreatectomy; 21 total specimens were obtained. Three out of 8 noninvasive tumors were fluorescent (mean TBR 2.59 ± 2.57). Twelve out of 13 invasive malignancies (n = 12 pancreatic adenocarcinoma, n = 1 cholangiocarcinoma) were fluorescent (mean TBR 4.42 ± 2.91). Fluorescence at the transection margin correlated with final pathologic assessment in 12 of 13 patients. Following neoadjuvant therapy, 4 of 5 tumors were fluorescent; these 4 tumors showed no treatment response on pathology assessment. One tumor had a significant treatment response and showed no fluorescence. CONCLUSIONS: Second window ICG reliably accumulates in invasive pancreatic malignancies and provides real-time feedback during pancreatectomy. NIR imaging may help to assess the response to neoadjuvant therapy.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Newton AD, Predina JD, Shin MH, et al. Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection. Ann Surg. 2019. PMID: 31188797. doi:10.1097/SLA.0000000000003201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。